Abstract

Introduction: Breast cancer is the second most common cancer in Indian women. Breast cancer is a signicant cause of worldwide morbidity and mortality. Mammography and ultrasound are used as the rst line of investigation for the early detection and localization of breast tumors. Mammography has high sensitivity in case of patients with fatty parenchyma however low sensitivity in case of patients with dense breasts, implants, and post-surgical scar, thus breast MRI with higher sensitivity and specicity due to its ability to depict excellent soft-tissue contrast has become increasingly important in the detection of breast cancer. DCE-MRI has improved specicity in characterizing breast lesions by analysis of time-intensity curves. Diffusion-weighted imaging can improve the sensitivity and specicity of MRI in the evaluation of breast lesions by calculating the ADC values a quantitative measure that is a useful tool for tumor detection and differentiating between benign and malignant breast lesions. To evaluate the role of diffusion-weighted MRI andObjective: dynamic contrast-enhanced MRI in differentiating benign from malignant breast lesions and to compare the ndings of diffusion-weighted MRI and dynamic enhanced MRI with histopathological or FNAC ndings. A totalMaterial And Methods: of 30 patients with palpable breast lumps with either positive or negative ndings on mammography and ultrasound were included in this study. All patients included in this study rst underwent lm-screen mammography. Ultrasonography was done with convex and linear probes. This was followed by MRI. T1W axial, T2W axial, SPAIR/ Fat Saturated T2 weighted axial images were acquired in appropriate imaging planes. Diffusion-weighted images were obtained using b values of 0 and 1000 and ADC values were calculated. Dynamic contrast-enhanced MR was performed using fat-suppressed 3D T1 weighted images after injection of gadolinium and time-intensity curves were generated. A single precontrast scan was followed by 4 post- contrast scans which were obtained for a total duration of 4 min 24 seconds. Findings of the MRI (Diffusion-weighted and dynamic contrast enhancement) were analyzed and correlated with histopathological and FNAC ndings to evaluate their use as a diagnostic modality. A total of 30 female patients presenting with palpable breast lumps were included in theResults: study. Out of 30 patients, 20 cases were malignant (66.67%) and 10 cases were benign (33.3%). Fibroadenoma accounted for a majority of benign lesions (4 out of 10 benign lesions) while IDC accounted for the majority of malignant lesions (15 out of 20 malignant lesions). Dynamic CE-MR is a reliable tool for differentiating between benign and malignant lesions based on kinetic curves. 7 out of 10 benign lesions showed a type I curve while the rest showed a type II curve while the majority (15/20) of malignant lesions showed a type III curve. 8 out of 10 benign breast lesions did not show restricted diffusion on DWI while all malignant lesions showed restricted diffusion on DWI. In our study, the mean ADC value for benign lesions was 1.59 x 10 mm/s while the mean ADC value for malignant lesions was 0.88 x 10 mm/s. Using the ROC curve, the cut-off value of ADC was calculated to be 1.19 x 10 mm/s which gives sensitivity and specicity of 95% and 90% respectively. The individual sensitivity for DCE-MRI and DWI was calculated to be 95% and 95% while the individual specicity for DCE-MRI and DWI was calculated to be 70% and 90% respectively. After a combined analysis of DCE-MRI and DWI using a positive result from any of the two techniques as malignancy, the sensitivity and specicity were 95% and 80% respectively.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call